Highlights
About
Cardiac Ultrasound with Real-time AI Guidance
UltraSight’s mission is to make diagnostic imaging more accessible by empowering medical professionals to successfully acquire timely and accurate cardiac ultrasound images anywhere. UltraSight's AI-driven software offers real-time guidance, making cardiac ultrasound accessible and efficient, which may lead to quicker diagnoses and improved patient care. In 2022, UltraSight won the Bristol Myers Squibb Improving Cardiovascular Disease Outcomes Challenge as the most “innovative cardiac technology.”
Additionally, the company was awarded a patent for its real-time guidance solution for ultrasound devices. UltraSight’s software has FDA 510(k) Clearance, is UKCA and CE Marked, and has Israeli AMAR Clearance to assist medical professionals in performing cardiac ultrasound scans.
Identity
| Name | UltraSight |
|---|---|
| Slug | on-sight-medical |
| Former names | On-Sight Medical |
| Type / kind | startup |
| Crunchbase ID | on-sight-b615 |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Jbdy5kKDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ness Ziona |
| HQ address | Pinhas Sapir St 8, Ness Ziona, Israel |
Web & social
| Website | https://ultrasight.com |
|---|---|
| https://www.linkedin.com/company/14836942 | |
| Twitter / X | https://twitter.com/UltraSightAI |
| YouTube | https://www.youtube.com/channel/UC4VTH2iX2cC7QbikF5dqLXw |
Classifications
Funding
| Total raised | $15.2M |
|---|---|
| Current stage | Series B |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}